Virginia Commonwealth University

VCU Scholars Compass
Theses and Dissertations

Graduate School

2010

Cell-Cell Junction Signaling Regulating DNA Double-Strand Break
Repair In Breast Cells
SINDUJA ETHIRAJ
Virginia Commonwealth University

Follow this and additional works at: https://scholarscompass.vcu.edu/etd
Part of the Biochemistry, Biophysics, and Structural Biology Commons
© The Author

Downloaded from
https://scholarscompass.vcu.edu/etd/132

This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has
been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass.
For more information, please contact libcompass@vcu.edu.

i

Cell-Cell Junction Signaling
Regulating DNA Double-Strand Break
Repair In Breast Cells
Thesis submitted to the faculty of the Molecular Biology and Genetics Program,
Department of Biochemistry and Molecular Biology, School of Medicine,
Virginia Commonwealth University
in partial fulfillment of the requirements for the
degree of

Master of Science
In
Molecular Biology and Genetics
(Majoring in Biochemistry)

SINDUJA ETHIRAJ
Department of Radiation Oncology
Virginia Commonwealth University
Richmond, Virginia
August 12, 2010

ii

ACKNOWLEDGEMENTS
I wish to express my sincere gratitude to all those people who helped and supported me
during MS study.
First of all, I am heartily thankful to my advisor, Dr. Aylin Rizki, for her patient
supervision, support and guidance in the right direction during every step of my
research. She always encourages us and extends her support to become a part of
public & poster presentations that helped in molding myself better during such
situations. Without her persistent help this thesis would have not been possible. I am
also grateful to her for providing me financial support to do MS.
Dr. Lawrence Povirk and Dr. Sarah Speigel have been kind enough to serve as a
member of advisory committee and I appreciate them for their valuable and constructive
comments on my thesis that enabled me to make necessary improvements.
I thank Shayalini Wignaraja & Bret Adams for sharing the procedure to probe γ-H2AX
on western blots. I would also like to thank my lab members Anna Miller, Renyan Liu,
Siddharth Saini & Jedd Ticar for their timely help and for creating a pleasant and
memorable working atmosphere.
I would like to extend my gratitude to FACS and confocal facilities of Massey Cancer
Center. I acknowledge American Cancer Society Institutional Research Grant and
NIH/K12 BIRCWH (Building Interdisciplinary Research Careers in Women’s Health) for
funding.

iii

I owe my deepest thanks to my dearest mom who had always been supportive and for
encouraging me to pursue my studies abroad. This thesis could not have been
accomplished without Mohanraj, my husband who had always been a silent supporter,
encouraging and helping me at difficult times.

iv

ABSTRACT
Genomic instability and acquisition of invasiveness through the basement membrane
extracellular matrix (ECM) are two major processes for epithelial cell malignancy in
breast cancer. DNA double-strand break repair (DSBR) is one of the processes that get
misregulated during breast cancer progression. In addition, radiation induced breaks
such as those induced during radiation therapy to treat breast cancer patients are
repaired by DSBR, rendering this pathway relevant for therapy as well. DSBR can occur
either by homologous recombination (HR) or non-homologous end-joining (NHEJ). HR
is accepted as the more error-free pathway. HR is regulated by the cell cycle status
such that an increase is observed in G2/M, whereas NHEJ is observed throughout the
cell cycle.
Previous data show that ECM signaling regulates HR, as well as the kinetics of ionizing
radiation (IR) induced complex formation at break sites, or foci kinetics. Both human
breast epithelial cell lines and primary mouse mammary epithelial cells were used to
show that the ECM receptor β1-integrin is necessary and sufficient in down regulating
HR, as well as IR induced foci formation kinetics for the DSBR proteins RAD51,
MRE11, and

γ-H2AX in single mammary epithelial cells. RAD51 is required for most

HR, whereas MRE11 and

γ-H2AX function in HR as well as DNA damage signaling.

Interestingly, ECM signaling up-regulates HR in cells that have “correct” in vivo-like cellcell junctions. Based on the observation that single cells and junctioned cells respond to
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ECM in exact opposite manner, I hypothesized that ECM signaling may interact with
cell-cell junction signaling pathways in regulating DNA repair.
To test this hypothesis, I asked whether the main breast epithelial adherens junction
cadherin, E-cadherin, is involved. I blocked E-cadherin function using a monoclonal
antibody MB2. The function blocking was demonstrated by the loss of cell-cell junction
interactions and observation of increased cell scattering using phase microscopy. I then
asked whether blocking E-cadherin altered the expression and localization of proteins
related to DNA repair. Indirect immuno-fluorescence showed that in the E-cadherin
blocked non-tumorigenic breast epithelial cell line HMT-3522 S1 there is an upregulation of nuclear

γ-H2AX and RAD51, as well as an increase in the proliferation

marker Ki67. In non-proliferative MB2 blocked cells there is an upregulation of

γ-H2AX

and reduced Ki67. Furthermore, in these proliferative and non-proliferative blocked cells
we were able to see lower levels of β-catenin near the cell membrane and an increase
in its levels inside the cell especially in the nucleus. The latter has been confirmed also
by western blot technique comparing the nuclear and cytoplasmic fraction expression.
In addition, western blots showed that total RAD51 level was down-regulated by Ecadherin blocking and

γ-H2AX levels were found to be higher in proliferative and non-

proliferative MB2 treated cells. MB2 treated cells have a higher frequency of HR in the
absence of ECM and in the presence of ECM, MB2 blocking abolishes the ECM effect
on HR. Furthermore, in the absence of ECM, RAD51 siRNA treated cells downregulated HR but the absence of RAD51 did not down regulate HR in the presence of
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ECM. I was not able to see any difference in the phosphorylated forms of β-catenin
such as Tyr-142, Ser-45 and Tyr-86 that has the ability to enter into the nucleus.
Therefore, E-cadherin was found to block nuclear β-catenin, RAD51 and

γ-H2AX in a

proliferation-independent manner. E-cadherin also was necessary for ECM to upregulate HR. The up-regulation of HR by ECM was only slightly dependent on RAD51
suggesting a novel E-cadherin-dependent and RAD51-independent HR component in
breast epithelial cells in contact with ECM as they are in vivo in the normal breast
tissue.
These experiments will help us to understand the role of E-cadherin and β-catenin in
DNA double-stand break repair directly, as well as in combination with ECM signaling.
Both alterations in integrin mediated signaling and cell-cell junction integrity contribute
to breast cancer progression by rendering breast epithelial cells more invasive. My
project will shed light on whether these invasive processes also alter DNA repair and
contribute to genome stability. Understanding of the interrelationships among integrin
signaling, cell-cell junctions, and genome stability will contribute to understanding
normal breast cell processes and open up investigations on how these may go awry in
cancer progression.
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INTRODUCTION
Cells create the correct configuration of their microenvironment by secreting and
manipulating extracellular matrix (ECM) components. ECM in turn serves as a support
for the development of all structures that comprise a functional organism and are also
involved in regulating inter-cellular communication. Cells recognize a functional ECM
using mostly the major cell receptor, integrins. Integrins play a vital role in the alteration
of cellular growth and tumor progression through the regulation of gene expression,
apoptosis, cell adhesion, proliferation, migration, angiogenesis[1, 2] and proteinase
secretion[3].
EXTRACELLULAR MATRIX (ECM)
In mammary glands, the epithelial cells reside on thin sheet-like structures of ECM
known as the basement membrane (BM). Type IV collagen, laminin, heparin sulphate
proteoglycans (HSPGs) and nidogen/entactin are some of the major components of BM.
Type IV collagen is a major structural protein of BM. They are heterotrimers composed
of three alpha chains. There are 6 genetically distinct alpha chains encoded by genes
COL4A1 through COL4A6 located in chromosome 2q36, 13q34 and Xq22 (Figure1) [4].
These alpha chains can arrange into at least three different forms viz., [α1(IV)]2α2(IV),
[α3(IV)]2 α4(IV) and [α5(IV)]2α6(IV). [α1(IV)]2α2(IV) was found to be present ubiquitously
in all BMs. Apart from this, α5(IV) and α6(IV) chains were found to be present in the BM
of mammary gland [5]. In situ hybridisation and immunohistochemistry have revealed
that assembly of α5(IV)/α6(IV) is defective in the invasive stages of breast cancer [6].

3

Furthermore, many isoforms also exist for these 6 forms of type IV collagen alpha
chains further contributing for its diversity.
Each type IV collagen chain consists of three domains: an N-terminal 7S domain, a
middle triple-helical domain, and a C-terminal globular noncollagenous (NC1) domain
(Figure 2). It is speculated that the triple-helical type IV collagen molecules self
associate via their NC1 domains to form dimmers and also at the glycosylated Nterminal 7S domain to form tetramer (lateral association). These interactions form the
nucleus of type IV collagen scaffold which will further evolve into a type IV collagen
suprastructure representing spider web-like scaffolds with the help of the end to end
and lateral associations (Figure 3) [7].
Laminin is a trimer containing α, β, and

γ chains and are available in 12 different forms.

Laminin is believed to initiate BM scaffold formation at the basolateral surface of the
cells. Laminin polymer anchors to the cell surface via site-specific interactions with
integrins (especially β1-integrins) and dystroglycans. The type IV collagen scaffold in
turn associates with laminin polymers on the cell surface via nidogen/entactin bridging.
[7].
Most of the knowledge on signaling and phenotypic consequences of BM was gained
from the mouse Engelbrecht Holm-Swarm (EHS) sarcoma tumor secreted ECM used in
culture.
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These EHS cells produce and accumulate BM components within the tumor tissue that
can be easily isolated [7, 8]. We use EHS (BD Matrigel™ Basement Membrane Matrix,
Growth Factor Reduced) as ECM for our culture experiments. It is a solubilized
basement membrane preparation extracted from the EHS mouse sarcoma, a tumor rich
in extracellular matrix proteins that has laminin, collagen IV, heparan sulfate
proteoglycans, and entactin/nidogen. BD Matrigel Matrix also contains TGF-β,
epidermal growth factor, insulin-like growth factor, fibroblast growth factor, tissue
plasminogen activator and other growth factors which occur naturally in the EHS tumor.
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Figure 1: Collagen genes in human. The location of six different genes that encodes
for genetically distinct alpha chains of collagen. The collagens are located in pairs and
in opposite orientation (head-to-head fashion) on three different chromosomes. The
different collagen genes are represented in different colors (Adapted from J Biol chem
268(35), 1993, pp. 26033–6, [4]).
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Figure 2. Schematic model of a type IV collagen. Three alpha chains are arranged to
form type IV collagen and is represented in the figure as single thick horizontal blue bar
for simplicity. It contains three domains. The triple-helical domain consists of ~1400
amino acids (aa) and consists of 22 imperfections within the Gly-X-Y motif. The NC1
domain is ~230 amino acids in length (Adapted from Nat Rev Cancer, 3(6), 2003, pp.
422–33, [7]).
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Figure 3. Formation of Type IV collagen network. Two NC1 domain associate to
form dimer while four 7S domain associate to form a tetramer. The dimer and tetramer
forms the nucleus for the Type IV collagen scaffold formation (Adapted from Nat Rev
Cancer, 3(6), 2003, pp. 422–33 [7]).
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INTEGRINS
Integrins are the major cell receptors that interact with ECM. They are heterodimeric
transmembrane receptors composed of α and β subunits [9]. There are 24 heterodimers
of integrin family formed from 18 α and 8 β subunits. Within this integrin family β1integrins, β2-integrins and αv-containing integrins are the 3 largest groups (Figure 4).
Different integrins can bind to different ECM components while some integrins can bind
to many ECM components. For instance, α1β1, α2β1, α5β1 integrins bind to collagens,
α6β4, α3β1 integrins binds to laminins and α8β1 binds to fibronectin, vitronectin and
nephronectin. Furthermore, the interactions between integrins and BM components are
altered when there is a structural change in BM components. For example, α1β1 and
α2β1 integrins bind to collagen IV and promote proliferation and migration in cells. But
when the collagen is degraded by MMP, αvβ3 integrin binds to the denatured collagen
IV but not α1β1 and α2β1 integrins.
Integrins can signal bidirectionally [10]. They can get information from extracellular
stimuli to induce intracellular changes (outside-in signaling) or from intracellular stimuli
to induce extracellular changes (inside-out signaling). The activation of integrins occurs
through inside-out signaling [11]. Normally integrins are expressed on the cell surface in
an inactive conformation, unable to productively bind to ECM. Through inside-out
signaling, talin binds to the cytoplasmic domain of integrin causing structural changes in
the extracellular domain of integrin leading to integrin activation [12]. This activation
increases the affinity of individual integrin for ECM ligands. Ligand-bound integrins
cluster first into unstable structures called nascent adhesions [13]. A subset of nascent
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adhesions progresses to dot like focal complexes, which can mature into larger focal
adhesions (FAs) and finally into streak-like fibrillar adhesions [14]. Once integrins are
activated and clustered they are able to transmit many intracellular changes by outsidein signaling and this occurs by the recruitment of Rho GTPases, Raf, Ras, FAK, and
MAPKs such as extracellular-signal-regulated kinases (ERKs) to the ECM ligandintegrin binding site [15].
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Figure 4. Representation of the integrin family. In vertebrates, the integrin family
contains 24 heterodimers. Different sets of integrin receptors bind to different
components of ECM (Adapted from Cell Tissue Res, 339, 2010, pp. 269–80, [16]).
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INTEGRINS AND CADHERINS
Various studies report a correlation between cell-ECM and cell-cell adhesions. In colon
cancer, inhibition of E-cadherin caused an up-regulation of α5 integrins [17]. In addition,
introduction of a dominant negative mutant E-cadherin into keratinocytes resulted in
reduction in expression levels and activity of α2β1 and α3β1 integrins [18, 19]. In
another study, introduction of E-cadherin to Xenopus-derived fibroblasts caused
downregulation of α3β1 integrin and reduced adhesion to fibronectin and laminin [20].
Furthermore, functionally inhibited-anti-cadherin antibodies have been shown to prevent
loss of α6 and β1- integrin in terminally differentiated keratinocytes [21].
Various experiments also have shown the effect of E-cadherin on the downstream
factors of integrin. For instance, ILK involved in integrin signaling pathway was reported
to promote β-catenin translocation to the nucleus while β-catenin through its
downstream factor TCF/LEF regulates the promoter for cyclin D1 [22, 23]. The above
evidences suggest that there is some cross talk between integrin signaling and Ecadherin pathway and are summarized in Figure 5. Previous results show that β1integrin mediated ECM signaling downregulates the homologous recombinational repair
of double-strand breaks in single cells but has the opposite effect in junctioned epithelial
cells [24], suggesting a cross-talk between cell-cell junction and ECM signaling that
functions in double-strand break repair. Here we study cell-cell junction signaling
involvement in double-strand break repair, focusing on adherens junctions previously
shown to interact with ECM signaling pathways.
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Figure 5. Relationship between E-cadherin and integrins in different cell lines
([17], [18, 19], [20], [21], [22, 23]).
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E-CADHERIN PATHWAY
Cadherins are one of the major proteins involved in cell-cell adhesion by forming
adherens junctions (AJ) between cells. Cadherins are also involved in regulating cell
shape, segregation, migration, proliferation and differentiation [25]. Within the cadherin
family of proteins, E-cadherin is found at the junctions of epithelial cells and mediates
cell-cell adhesion through homophilic interactions of their extracellular domains. Ecadherin also mediates contact inhibition of cell growth [26]. A reduced E-cadherin
expression was observed in at least 41% of human lobular breast carcinoma cases
mainly due to hypermethylation of E-cadherin promoter region [27].
The cytoplasmic tail of E-cadherin was found to interact with various proteins such as βcatenin and alpha-catenin that link E-cadherin receptor indirectly to cell signaling and
trafficking [28]. Furthermore, it is proposed that the E-cadherin/β-catenin interaction
occurs in the ER (endoplasmic reticulum) and is required for cadherin exit from ER.
Normally in the absence of Wnt signal, the cytosolic levels of β-catenin are low due to
sequential phosphorylation of serine and threonine residues of β-catenin by GSK3β
(glycogen synthase kinase-3β) and CK1 (casein kinase 1) within MDC (multiprotein
destruction complex) followed by proteasomal degradation [29]. In the presence of Wnt
ligand (secreted lipid-modified signaling protein); the receptor is activated causing MDC
to destabilize. As a result, the unphosphorylated β-catenin accumulates in the cytosol
and is subsequently translocated into the nucleus where it associates with TCF/LEF (T
cell factor/lymphoid enhancer factor) transcription factor. This leads to transcription of
Wnt target genes [30] (Figure 6).
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In addition, CCN6, a Wnt1 induced signaling protein 3 knock down in benign human
mammary epithelial cell lines (HME and MCF10A) led to down regulation of E-cadherin
[31].
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Figure 6. The Wnt Pathway. β-catenin is the main protein involved in the pathway and
the fate of this protein changes in the presence and absence of Wnt signaling (Adapted
from J. Hülsken, MDC, Berlin [32]).
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DOUBLE STRAND BREAK REPAIR AND CELL-CELL JUNCTIONS
Genomic instability is one of the main properties of malignant cell that lead to
acquisition of various forms of mutations. To maintain a stable genome, DNA doublestrand breaks (DSB) caused by ionizing radiation and DNA damaging chemicals should
be repaired. DSBs can be repaired by major repair pathways such as homologous
recombination (HR) or non homologous end joining method (NHEJ) (Figure 7). HR is
known for its error-free repair when compared to NHEJ [33]. Furthermore, HR is
predominant during S and G2 phase while NHEJ is upregulated during G1 phase of the
cell cycle [34].
In NHEJ, the DNA ends are processed to produce ligatable ends after which the ends
are ligated. In case of HR, the DSBs are first sensed by the MRN complex of proteins.
The MRN complex is a hetero-trimeric protein consisting of MRE11, RAD50 and NBS1.
MRE11 has DNA-binding domains and a domain with exonuclease activity that can also
interact with NBS1. NBS1 also has exonuclease activity and contains domains that
interact with MRE11 and ATM. RAD50 has walker A and B. Walker A and B are
separated by coiled-coil domains with a zinc-hook motif in the center (Figure 8)[35, 36].
When there is a DSB, MRE11 binds to the broken DNA ends through its DNA-binding
domain. NBS1 is recruited to this site as MRE11 contains an NBS1 binding domain.
RAD50 through its walker A and B tethers the DNA ends. Interaction of RAD50 with
MRE11 stimulates endonuclease activity of MRE11 in order to processes the DNA ends
to produce 3’overhangs. Recruitment of ATM as inactive dimer at DSB also occurs
after the assembly of MRN complex. Both by RAD50 that increases the local
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concentration of DNA ends and NBS1, the ATM gets activated into an active monomer
which in turn phosphorylates a number of substrates that are involved in HR and NHEJ,
including H2AX to

γ-H2AX by phosphorylating H2AX at ser139 (Figure 9)[35]. γ-H2AX

forms foci at and near the DSBs and also acts as a docking site for the DNA repair
proteins.
In addition to the MRN complex, also BRCA1 and CtIP are involved in the activation of
HR-mediated repair of DNA in the S and G2 phases of the cell cycle. After end
resection the 3’ overhangs invade the sister chromatids. These single stranded DNA
binds to single stranded binding protein, RPA (replication protein A). RAD51 binds to
the RPA bound ssDNA with the help of mediators and forms a nucleoprotein filament.
This is followed by strand invasion, synthesis of DNA by DNA polymerase and
resolution of junctions (Figure 9)[35].
Apart from the above explained HR that involves RAD51, there is also an RAD51independent HR that has been widely studied in S. cerevisiae. RAD51-independent
recombination pathway (RIRP) was predicted to occur by invasion of 3’end of the
broken chromatid into an intact non-homologous chromosome leading to non-reciprocal
translocations (Figure 10)[37]. Interestingly, in mammalian cells, a research group while
studying the effects of HR on cells expressing mutant RAD51, they were able to see
some residual level of HR taking place within these cells suggesting that there could be
a RAD51 independent recombination pathway in mammalian cells as well [38].
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Figure 7. The double strand break repair pathway. Picture showing the different
possibilities by which DNA double strand breaks can be repaired and their mechanisms
are explained in diagrammatic manner.
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Figure 8. Structure of RAD50. RAD50 contains two coiled-coil domains and a zinc
hook. There is walker A and B that are present at either ends of RAD50 molecule that
helps in tethering the broken DNA ends. (Adapted from J Appl Genet 49(4), 2008, pp.
383–396) [35, 36].
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Figure 9. Diagrammatic representation of double strand DNA repair. Left panel,
MRN complex is the first one to sense the double strand break before RPA and RAD51.
Right panel, a detailed function of all the three proteins of MRN complex (adapted from
J Appl Genet 49(4), 2008, pp. 383–396 [35]).
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Figure 10. RAD51-independent HR pathway. Figure shows a possible pathway by
which DNA double strand break can be repaired in a RAD51 independent manner
(adapted from Genetics, 158(3), 2001, pp. 959 -72 [37]).
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HUMAN BREAST EPITHELIAL CELL LINE MODEL
As a model for breast epithelial cells, S1 and S1 DR9 cells will be used in the
experiments. These breast epithelial cells were derived from a reduction-mammoplasty
specimen of a patient with fibrocystic breast disease and grown on a defined medium to
obtain HMT-3522 S1 cells (referred to as S1 cells from here on) [39]. S1 cells are
immortalized but non-tumorigenic when injected into nude mice [40]. Most importantly
for this project, S1 cells are dependent on the Epidermal Growth Factor (EGF) for
growth. Leaving out EGF from the growth media arrests the cells mostly in the G1
phase of the cell cycle (Figure 11). Double-strand break repair pathway frequency has
been shown to depend on which phase of the cell cycle the cells are in. Therefore, by
simply not providing EGF to cells, they can be stopped in G1 phase. HR is high in G2/M
phase. But since we use a GFP direct repeat sequence in S1 DR9 cells, we are able to
observe intrachromatid recombination events in G1 (Figure 12). This helps us to do
experiments on HR frequency that are reproducible as all cells will be in one phase of
cell cycle.
S1 DR9 cells are normal S1 cells into which two direct repeats of non-functional GFP
gene (DR-GFP) have been integrated [41]. The DR-GFP is integrated in the hprt
(hypoxanthine phosphoribosyl transferase) locus. The DR-GFP has a 5’s-GFP gene
that has a rare I-SceI endonuclease recognition site of 18bp length within it. DR-GFP
also has a 3’iGFP gene that has 0.8Kb homology for reparing the I-SceI cleaved s-GFP
and to restore its expression through homologous recombination, specifically by non-
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crossover gene conversion. This can occur between sister chromatids or by
intrachromosomal recombination (Figure 12).
But the GFP gene expression will not be restored if the double-strand break (DSB) is
repaired by non-homologous end joining method (NHEJ) (Figure 13). Thus the
expression of GFP reporter is used as a measure of homologous recombination. In
order to induce the break at the I-SceI recognition site, plasmid pBAS that expresses
the I-SceI endonuclease from an actin promoter is introduced into S1 DR9 cells. To
compare the transfection efficiency, a plasmid expressing GFP from the same promoter
is transfected into cells in parallel under the same experimental conditions.
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Figure 11. Percentage of non-proliferative S1 cells at different phases of cell
cycle. When the normal S1 cells with cell-cell junctions are treated with growth medium
without EGF, mostly the cells were found to be in G0 or G1 phase of cell cycle while
only a very low percentage of cells were in other phases of cell cycle after DSB
induction for up to 9 days.
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Figure 12. Possible DSB repair mechanisms at different phases of cell cycle.
During Go and G1 phase intrachromosomal recombination occurs to repair DSB by HR
while sister chromatid exchange occurs during G2, M and S phase of cell cycle.
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Figure 13. Assay for homologous recombinational repair of an induced DSB
within a direct-repeat substrate, DR-GFP assay.
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EFFECT OF ECM ON HR IN JUNCTIONED CELLS
Previously in our lab, DSB was induced in S1 DR9 cells by transfecting the I-SceI
endonuclease encoding pBAS after the cells formed cell-cell junctions (approximately
40% confluence). In the presence of ECM, the percentage of GFP positive S1 DR9 cells
increased indicating an up-regulation of HR as compared to its down-regulation in the
absence of ECM (Figure 14). The results were also consistent with primary mouse
epithelial cells with proper junctions. Furthermore, similar results obtained for nondividing S1 DR9 cells that have normal cell-cell junctions showing that the result is not a
secondary consequence of the effects of ECM on cell cycle.
EFFECT OF ECM ON HR IN SINGLE CELLS
Interestingly, single S1DR9 cells as compared to junctioned cells, ECM was found to
have an opposite effect. That is, HR was up-regulated in the absence of ECM and it
was down-regulated in the presence of ECM (Figure 15). Thus there were reciprocal
results for the effect of ECM on HR in the presence of normal cell-cell junction and in
single cells without in-vivo like cell-cell junction.
EFFECT OF ECM ON DNA REPAIR PROTEIN FOCI FORMATION AFTER IONIZING
RADIATION
Foci formation kinetics of S1 cells show that the effects of ECM via β1-integrin on DNA
repair proteins such as H2AX and RAD51 is modulated by ECM (Figure 16). In primary
mouse mammary epithelial cell organoids, in the presence of ECM, β1-integrin and cellcell junction,

γ-H2AX levels were up regulated. But in single S1 cells (absence of cell-
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cell junction),

γ-H2AX and RAD51 is down-regulated in the presence of ECM and β1-

integrin (Figure 16).

In addition, MRE11 foci kinetics is altered by ECM in single cells

(Figure 16). These results suggest that cell-cell junctions alter the effect of ECM and
ionizing radiation induced foci formation. In addition

γ-H2AX,

RAD51 and MRE11

complex of proteins are candidates to test for nuclear modulated effect on HR.
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Figure 14. Effect of ECM on HR in proliferative and non-proliferative cells. The
number of GFP positive cells is directly related to HR frequency. And the GFP positive
cells in the presence and absence of ECM and EGF were shown in the bar graph.
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Figure 15. Non-Tumorigenic Human Cell Line S1, Single Cells. In case of S1DR9
cells that were stopped from proliferation immediately after seeding the cells, the cells
remain single on the culture flask. The frequencies of HR for single and normal
proliferating cells were compared in the presence and absence of ECM.
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Figure 16. Ionising radiation induced foci kinetics of γH2AX, MRE11 and RAD51.
Foci formation kinetics of cells after 3Gy, in the presence or absence of ECM or A2BII
β1-integrin blocking antibody at 100µg/ml for S1 and Ha2/5 at 10µg/ml for mouse cells.
*,t-test p<0.05 and significant.
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HYPOTHESIS
Previously, ECM signaling via β1-integrin was shown to up-regulate homologous
recombination (HR) in the presence of normal cell-cell junctions whereas it downregulated HR in the absence of junctions in single cells. This led us to ask whether cellcell junctions modulate the effects of ECM on homologous recombination. Specifically,
we hypothesize that adherens junction signaling that has intersecting signaling
components with ECM signaling can modify the ECM effect on HR.
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METHODS AND
MATERIALS
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METHODS AND MATERIALS
CELLS USED
S1 cells (normal mammary epithelial cell line) were used for western blotting and
indirect immunofluorescence techniques [40, 42]. S1 DR9 cells were used for all flow
cytometry analysis. Since, S1 DR9 cells contain two direct repeats of non-functional
GFP genes and when a double-strand break is induced within the GFP gene at I-SceI
recognition site and if the break is repaired by homologous recombination then the GFP
gene becomes functional [24, 43]. Therefore, to measure the frequency of homologous
recombination, I used these cells.
PLASMIDS AND siRNA USED AND THEIR TRANSFECTION
pBAS plasmid and pGFP plasmids were used for DR-GFP experiments [24]. pBAS
encodes for I-SceI endonuclease. pGFP encodes GFP protein and are used as positive
control as well as to measure the transfection efficiency. Both the plasmids are resistant
to ampicillin. These plasmids were amplified by first transforming them into competent
E. coli cells. The transformed E.coli cells were plated on LB agar containing ampicillin
and incubated overnight at 37ºC in order to select the transformed cells. Individual
colony of cells containing the plasmid were further amplified first in 3ml and then in
250ml LB liquid medium containing ampicillin by incubating them at 37ºC overnight in a
shaker at 250rpm. Then the plasmids were isolated using Maxiprep (Qiagen) for
transfection into mammalian cells (jetPEI transfection reagent, polyplus). siRNA against
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RAD51 (siGENOME SMART pool of human RAD51, Dharmacon) was used in HR
experiments. 90 µl (20 µM) of RAD51 siRNA or scramble control siRNA was transfected
into S1 cells in T-75 flask using 75 µl of Dharmafect transfection reagent.
ANTIBODIES
RAD51 from Calbiochem (Cat. No. Ab-1, PC130, 1:1000 dilution) and Novus (Cat.
No.13E4, 1:5000 dilution) have been used for indirect immunostaining and western blot.
Ki67 from Novocastra (Cat. No. NCL-Ki67p (Ki67p-CE), 1:100 dilution) or Calbiochem
(Cat No., 1:100 dilution) was used for indirect immunofluorescence. β‐catenin (Cat. No.
BD: 610153, BD biosciences, 1:50 dilution) and γH2AX (Clone JBW301, Millipore, Cat.
No. 05-636, 1:75) were used for both indirect immunofluorescence technique. Ecadherin from Abcam (Clone MB2, Cat. No. ab8993) was used as blocking antibody
and She7-78 from Axxora (Cat. No. ALX-804-203, 1:150 dilution supplemented with
10mM calcium chloride) was used for indirect immunofluorescence. NBS1 (Cat. No. BD:
611870, 1:100 dilution), RAD50 (Cat. No. BD: 611010, 1:500 dilution) and MRE11 (Cat.
No. BD: 611367, 1:250 dilution) from BD transduction laboratory, α-tubulin from Sigma
(Cat. No. T6074-200Ul, 1:1000 dilution) and Lamin B (Santa Cruz, Cat. No. sc-6216,
clone C20, 1:200 dilution) were used in western blotting.
INDIRECT IMMUNOFLUORESCENCE
To study the expression of DNA repair proteins on MB2 treated and control cells, I did
indirect immunofluorescence technique. For this 40,000 S1 cells were plated on each
well of a 4-well chambered slide and incubated for 3-4 days. Once the cells formed cell-
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cell junctions, cells in each well were treated with MB2 at three different increasing
dilutions (1, 2 and 5µg/ml) and one well was used as control (MB2 untreated). After
treatment, the cells were incubated for another 48 hrs. Then the cells were subjected to
indirect immunofluorescence technique. For this, the cells were washed with PBS (pH
7.4) and were treated with 0.5% triton-100 in CSK buffer (100 mM NaCl, 300 mM
sucrose, 10 mM Pipes, 5 mM MgCl2, 0.25 mM NaF) with protease inhibitor (1:1000
dilution) for 10 min on ice. Then they were washed twice using CSK buffer containing
protease inhibitor for 5 min each and fixed using 4% paraformaldehyde in CSK buffer
(pH 7.4) at room temperature for 20 min followed by washing thrice for 20 min with
PBS/glycine. Further, the cells were blocked for 1 hour using 10% goat serum in IF
buffer. Primary antibodies were mixed with the blocking solution and dispensed into the
wells. Then the chambered slides were wrapped with parafilm and placed in humidified
chamber at 4ºC overnight to avoid drying of the antibody solution. Next day, the slides
were washed thrice with IF buffer for 20 min with gentle agitation followed by secondary
antibody treatment (1:400 dilution) for 1 hour in dark. Then the slides were washed
thrice using IF buffer for 20 min followed by nuclear attaining using DAPI (1:10000
dilution from 10µg/ml stock solution) for 10 min. After 10 min of washing in IF buffer,
coverslip was placed over the slide with Vectashield and viewed under the fluorescence
microscope. Same amount of exposure time were used for each slide to view all 4 wells
to compare the expression levels of DNA repair proteins in control and MB2 treated
cells at different dilutions.
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WESTERN BLOTTING
S1 cells grown in T-75 flasks were treated with 5 µg/ml MB2 and incubated for 48 hours.
Control cells were also grown simultaneously that were not treated with MB2. These S1
cells (MB2 treated and untreated) were lysed to prepare whole cell lysate and cytosolic
and nuclear extracts. In order to prepare whole cell lysate, the cells were trypsinized
using 0.25% trypsin for 10 minutes followed by the addition of SBTI (soy bean trypsin
inhibitor) in 10ml DMEM/F12 medium. The cells collected by centrifugation were
washed with PBS and lysed by sonication in 100µl of RIPA buffer (5 M NaCl, 1 M TrisHCl, 500 Mm EDTA, 2% SDS, 1% NP-40, 1% deoxycholate, 200 mM NaVO4, 250 mM
NAF and protease inhibitor). Then the lysed cells were centrifuged at 12,000 rpm for 10
min at 4ºC. Supernatant was decanted into a separate tube and stored at - 85ºC. Protein
estimation was done for the whole cell lysate obtained using BIORAD Dc protein
estimation kit with serially diluted BSA in water as standards. Following protein
quantification of whole cell lysates, they were run in SDS PAGE gel and transferred
overnight onto nitrocellulose membrane at 20 mA. The transferred blot was blocked for
1 hour with 5% milk and 1% BSA in TBST (Tris buffered saline with 0.05% tween-20)
and probed for a specific protein using a primary antibody in TBS/TBST buffer overnight
at 4ºC. Membranes were then treated with anti-mouse/rabbit secondary antibody
(1:5000 dilution) for 1 hour at room temperature and viewed under LICOR imager
(Odyssey v1.2 software) at a wavelength of 700nm for anti-rabbit antibodies and 800nm
for anti-mouse antibodies. The bands are quantified using Odyssey LICOR infrared
imaging software v1.2.
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γ-H2AX LYSATE PREPARATION AND WESTERN BLOTTING
Cell monolayer in T-75 flask were first washed with PBS and then are scraped from the
flask after spreading 500µl of laemilli buffer (working solution) on the surface of the
flask. The working solution for laemilli buffer was prepared by mixing 4750ul Laemilli
buffer (BioRad cat# 161-0737) in 250ul Hem buffer (2-mercaptoethanol from Fischer
cat# 03446I-100) and by finally making up the volume to 10ml with water. The scraped
cells in laemilli buffer were lysed using a sonicator and heated in a 100ºC water bath for
7 min. The lysate was then spun at 14,000 rpm for 5 min and stored at 20ºC until
loading it in the SDS PAGE gel.
The lysate was spun at 14,000 rpm for 5 min before loading them in the 12% SDS
PAGE gel. 30 µl of sample volume loaded per well and run at 60 V for 150 min. Then
the gel was transferred on to the PVDF membrane (0.2 µm thick pore size). The PVDF
membrane was first activated in methanol for ~1 min and washed in transfer buffer for
3-5 min before using it for transferring by western blotting method. Then after
transferring overnight at 20 mA for 740 min, the blot was washed in blocking buffer
containing 1ml of 1% casein in 9 ml of PBS for 50 min -1 hour. Then the blot was
incubated with the primary antibody (1:1000 dilution of

γ-H2AX

from Millipore, clone

JBW301, catalogue no. 16-193) in blocking buffer at 4ºC overnight. Next day, the blot
was washed with PBST (contains 200 µl Tween 20 in 1litre PBS) 4 times for 15 min
each. The blot was treated with anti-mouse secondary antibody (1:5000 dilution) in the
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blocking buffer for 1.40 hours and washed again with PBST 4 times for 15 min before
scanning.
TOTAL AND ACTIVATED β1- INTEGRIN EXPRESSION ON CELL SURFACE
S1 cells were trypsinized and 500,000 cells were taken in 10 microcentrifuge tubes. Out
of ten, one tube was used as control without primary and secondary antibody treatment,
three was used as secondary control (treated just with secondary antibody and not
primary antibody) to subtract the background effect due to seconday antibody, three
was used for probing total β1‐integrin and remaining three for probing activated β1‐
integrin levels in cells. The cells were first centrifuged at 8000 rpm for 5 min to remove
the growth medium. Then the cell pellet was washed with 1 ml of FACS buffer (5% FBS
and 0.1% sodium azide in 100 ml PBS) thrice by resuspending in FACS buffer and
centrifuging at 5000 rpm for 5 min. Then the cells were treated with 50 µl of primary
antibody (either total or activated β1‐integrin) in FACS buffer at 1:10 dilution for 1 hour.
This mixture was then re-suspended every 15-20 min up to 1 hour. The cells were
washed thrice in FACS buffer by re-suspending the cell pellet in 1 ml FACS buffer and
centrifuging the cells at 5000 rpm for 5 min. Then the cells were treated with 50µl of
secondary antibody in FACS buffer at 1:100 dilution for 30 min. The mixture is resuspended every 15 min during secondary antibody treatment. Later, the cells were
washed with 1ml FACS buffer thrice as before. The cells were fixed by resuspending
the cell pellet in 100 µl of 2% paraformaldehyde in PBS at pH 7 and stored at 4ºC. The
cells were suspended in 500 µl PBS before running on flow cytometer.
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RESULTS
E-CADHERIN BLOCKING AND CONFIRMATION
Since ECM has a reciprocal effect on HR in the presence and absence of cell-cell
junctions I was interested to know the effect of cell-cell junctions on DNA repair
proteins. As E-cadherin is the major protein that is involved in adhesion of adjacent
breast epithelial cells together I tried to find out whether this cell-cell junction protein is
the one that is responsible for the reciprocal effect on HR. To do this, I used MB2
antibody. MB2 blocking antibody specifically reacts with 80 KD trypsin-resistant
extracellular domain of E-cadherin that is present on the cell surface. When S1 cells at
~40% confluence are treated with 5 µg MB2 antibody per ml of H14 growth medium
containing EGF and incubated for 48 hours, S1 cells were found to be scattered. The
adhesion between adjacent cells appeared to be less when compared to control cells
under light microscope (Figure 17). Thus, MB2 antibody causes morphological changes
in S1 cells that are consistent with diminished adherens junction function. When ~40%
confluent S1 cells are treated with ECM, the cells look more compact than without ECM
and in case of ECM and MB2 treated cells, the scattering was found to be lesser than
cells treated with MB2 in the absence of ECM (Figure 17A).
If ~40% confluent S1 cells were treated with H14 growth medium without EGF for 4
days, the cells stop from proliferating (Figure 17B). When to these non-proliferating cells
MB2 antibody was added (5 µg/ml, 48 hours), cell scattering was found to be lesser
than in MB2 treated normal proliferative cells. The cell morphology of ECM and ECM
plus MB2 treated non-proliferative cells are also shown in Figure 17B.
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To further confirm that MB2 antibody blocks E-cadherin, I seeded S1 cells in a 4-well
chamber slide and incubated until the cells form cell-cell junctions. Then cells in each
well were treated with MB2 antibody at different concentrations (1 µg/ml, 2 µg/ml and 5
µg/ml).

After

48

hours

of

incubation

the

cells

were

fixed

and

indirect

immunofluorescence was performed against E-cadherin on MB2 treated and untreated
cells. Results showed that the control cells have a thin line of E-cadherin between two
adjacent cells but it is absent in MB2 treated cells (Figure 18). The E-cadherin signal
observed between two adjacent control S1 cells is due to the presence of homophillic
interactions between E-cadherin of adjacent cells and this interaction is abolished in
MB2 treated cells further confirming that MB2 blocks E-cadherin protein function at least
after 48 hours (Figure 18).
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A. PROLIFERATIVE CELLS (+EGF)

B.NON-PROLIFERATIVE CELLS (-EGF)

Figure 17. Cell morphology of proliferative and non proliferative S1 cells with
different treatments. A, changes in the morphology of proliferative cells with and/or
without ECM and MB2 blocking. S1 cells were grown up to ~40% confluent by
incubating for 3-4 days. ECM (10%) and/or MB2 blocking antibody (5 µg/ml) is added
after the cells became 40% confluent and incubated for 48 hours. B, morphological
changes in non-proliferative cells with and/or without ECM and MB2 blocking. S1 cells
were grown up to ~40% confluent by incubating for 3-4 days and treated with growth
medium without EGF for 4 days to stop them from proliferating. ECM (10%) and/or MB2
blocking antibody (5 µg/ml) is added after the cells became 40% confluent and
incubated for 48 hours.

44

Figure 18. Effect of E-cadherin blocking in S1 cells. The Top panel, DAPI staining;
Bottom panel, corresponding E-cadherin staining. 5 µg/ml of MB2 antibody is the
optimal concentration used to block S1 cells.
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EFFECT OF E-CADHERIN ON DNA REPAIR PROTEINS IN PROLIFERATIVE CELLS
As a next step, I was interested to find out whether E-cadherin is the cell-cell junction
protein that is involved in modulating HR. For this, I tried to look at the effect of DNA
repair proteins by blocking E-cadherin. Therefore, I treated the S1 cells with different
concentrations of MB2 and after 48 hours of incubation the cells were fixed and indirect
immunofluorescence was performed against DNA repair proteins

γ-H2AX and RAD51.

In addition, proliferative marker Ki67 was examined. β-catenin (protein that binds to the
cytosolic domain of E-cadherin) localization was also determined since, its movement
from the cell junction to the nucleus could have down-stream consequences in DNA
repair either directly or indirectly via altering transcription or signaling events.

Ki67
Ki67 stains the nucleus of viable and proliferation-proficient cells. I was able to see
22.6% (SD = +/- 0.1) positive cells in normal S1 cells (control). In MB2 treated cells
(5µg/ml), 48% (SD = +/- 0.04) of cells were found to be positive (Figure 19). These
results suggest that the MB2 treated cells have twice the amount of proliferative cells
when compared to control cells. These results are consistent with a role for E-cadherin
in reducing growth by contact inhibition and show that I blocked this E-cadherin function
by MB2 treatment of S1 cells.
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β-catenin:
β-catenin is a protein that binds to the cytoplasmic domain of E-cadherin and connects
E-cadherin to the actin cytoskeleton indirectly. It is also capable of entering into the
nucleus and binding to the transcription factor TCF/LEF to up-regulate genes such as
cyclinD and c-myc in response to Wnt signaling. In order to determine the effect of Ecadherin blocking on β-catenin in S1 cells, we did indirect immunofluorescence. In
control cells, β-catenin appeared to be around the inner side of the cell membrane
attached to E-cadherin as expected but in MB2 treated cells β-catenin was more
concentrated in the nucleus and was observed to be lining the inner side of the
membrane attached to the cytosolic domain of E-cadherin (Figure 20). Considering cells
that have β-catenin in the nucleus as positive cells, I was able see 12% (SD = +/- 0.03)
positive cells in MB2 treated cells while control cells did not have any positive cells (0%
SD = 0) (Figure 20).

γ- H2AX:
γ-H2AX

is a DNA repair protein and can be seen as foci near double strand DNA

breaks. Its foci formation kinetics in response to ionizing radiation was altered by ECM
in opposite direction. In the presence and absence of cell-cell junctions, I determined if
E-cadherin affects its expression or localization. These were done in the absence of
ionizing radiation to determine if E-cadherin has effects on the basal levels of
There were 17% (SD = +/- 0.08) of MB2 treated cells containing

γ-H2AX.

γ- H2AX foci but the
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control cells did not have γ- H2AX foci in their nucleus (0%; SD = 0) (Figure 21) and this
difference was significant (p = 0.03). These results suggest that either the basal level of
DNA damage is increased or the cells have an altered basal state or concentration of
DNA damage protein such as

γ-H2AX

in the absence of E-cadherin at cell-cell

junctions. Alternatively, increased proliferation could increase proliferation could
increase replication blocks and γ-H2AX foci.

RAD51:
RAD51 is required for most HR and was found to have altered foci kinetics by ECM
signaling. To find out if it could be modulated by cell-cell junctions, I determined the
effects of E-cadherin blocking on RAD51 levels in the absence of exogenous damage.
Indirect immunofluorescence against RAD51 revealed 5% (SD = +/- 0.002) increase of
RAD51 as large nuclear “foci” in MB2 treated cells when compared to control cells (0%,
SD = 0) (Figure 22). The large blobs of RAD51 in the nuclei are not the typical foci
observed after ionizing radiation. Whether these accumulations of RAD51 are active
complexes or a means for storing inactive complexes remains an open question.
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A.

B.

p = 0.03

Figure 19: Ki67 expression in normal and MB2 treated S1 cells. A, Top pannel,
DAPI (nuclear) staining of control and MB2 treated cells respectively; Bottom pannel,
Ki67 staining in control and MB2 treated cells. B, The average (mean) number of Ki67
positive cells divided by the number of DAPI nuclei (y axis) in normal and in MB2
treated cells at different concentrations (1 µg/ml, 2 µg/ml and 5 µg/ml) (x axis) were
represented as bars. The error bars represent standard deviation of mean (N=2), with a
minimum of 2 wells and 200 cells per well counted per experiment. p-value is calculated
by comparing control and MB2 treated cells at 5 µg/ml concentration.
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A.

B.
p = 0.04

Figure

20.

Effect

of

E-cadherin

blocking

on

β-catenin

indirect

immunofluorescence in S1 cells. A, Top panel, DAPI staining of control and MB2
treated S1 cells. Bottom panel, β-catenin staining on control and MB2 treated cells. B,
the average (mean) number of positive nuclei divided by number of DAPI in control cells
as y-axis and cells treated with increasing concentrations of MB2 blocking antibody as
x-axis. The error bars represent standard deviation of mean (N=2), with 2 wells and
minimum of 200 cells counted per well in each experiment. p-value is calculated by
comparing control and MB2 treated cells at 5 µg/ml concentration.
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A.

B.

p = 0.03

Figure 21. Indirect immunofluorescence of
cells. A, Bottom panel,

γ- H2AX on control and MB2 treated

γ- H2AX staining on control and MB2 treated cells and their

corresponding DAPI staining in the Top panel. B, shows a graphical representation of
the average (mean) number of positively stained

γ- H2AX nuclei divided by number of

DAPI (y-axis) against different concentration of MB2 (x-axis). The error bars represent
standard deviation of mean (N=2), with 2 wells and a minimum of 200 cells counted per
well in each experiment. p-value is calculated by comparing control and MB2 treated
cells at 5 µg/ml concentration.
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A.

B.
p = 0.0004
00.00.000

Figure 22. RAD51 expression on normal S1 cells and MB2 treated cells. A, Bottom
panel, RAD51 indirect immunostaining. Top panel, DAPI staining for the control cells
and MB2 treated cells. B, bar graph representing the average (mean) number of RAD51
positive nuclei divided by DAPI (y-axis) in control and cells treated with increasing
concentration of MB2 treatment (x-axis). The error bars represent standard deviation of
mean (N=2), 2 wells and a minimum of 200 cells per well per experiment. p-value is
calculated by comparing control and MB2 treated cells at 5 µg/ml concentration.
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EFFECT OF E-CADHERIN ON DNA REPAIR PROTEINS IN NON-PROLIFERATIVE
CELLS
Previously, S1 cells were cultured in the presence of EGF and the effect of E-cadherin
blocking was determined in dividing cells. Proliferation of MB2 treated cells was found to
be higher than control cells as there was an increased Ki67 positive nucleus in MB2
treated cells than control cells. It has been found that the levels of RAD51 are cell cycle
regulated being lowest in G0/G1 phase, higher in S phase and the highest in G2/M
phase [44]. γ-H2AX levels have been revealed to be 3x levels higher in G1 than in S or
G2/M phase of unirradiated cells [45]. So, to find out whether increase in

γ-H2AX and

RAD51 in MB2 treated cells is due to proliferation or MB2 blocking, I performed indirect
immunofluorescence in non proliferative cells.
Ki67:
Ki67 expression was low in all cells due to lack of EGF in growth medium of S1 cells. In
control cells there were 8% (SD = +/- 0.08) positive cells and in MB2 treated cells
(5µg/ml) there were 3% (SD = +/- 0.03) positive cells (Figure 25). The p-value for control
and MB2 treated cells was not found to be significant.
β-catenin:
In non-proliferative cells, β-catenin (Figure 24) was found to be less near the membrane
than in cytosol and / or nucleus in MB2 treated cells (1.4%, SD = +/- 0.02) when
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compared to control cells (0%, SD = 0). This again confirms that E-cadherin function is
blocked by MB2 antibody. Here, I found that MB2 treated non-proliferating cells also
increased β-catenin nuclear positive cells. However, the number of positive cells having
β-catenin in the nucleus of MB2 treated cells was lesser in non-proliferative cells when
compared to proliferative cells.

γ- H2AX:
To ask whether the MB2 induced nuclear

γ-

H2AX in proliferating cells is due to

increased proliferation or not, I did indirect immunofluorescence with non-proliferating
S1 cells in the absence of EGF. Interestingly, percent

γ- H2AX foci containing nuclei

were significantly higher in MB2 treated cells (15%, SD = +/- 0.2) than in control cells
(0.1%, SD = +/- 0.002) in a way similar to proliferative cells (Figure 25). The number of

γ- H2AX positive percent was comparable in proliferating and non-proliferating cells.
Thus, this confirms that the increase in

γ-

H2AX levels in proliferative cells is not

because of increased proliferation but as a consequence of MB2 blocking and due to a
more direct effect on the DNA damage and repair pathway, including

γ-

H2AX

phosphorylation.
When the cells were treated with medium without EGF for 6 days instead of usual 4 day
treatment, the

γ-

H2AX foci was seen in both control (34%, SD=+/- 0.4) and MB2
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treated cells (38%, SD=+/- 0.5) to a similar extent. There was no significant difference in
the γ- H2AX foci containing cell percentage between control and MB2 treated cells. But
the foci were found to be larger in MB2 treated cells than in control cells. This qualitative
observation needs to be further verified by foci size quantification in future experiments.
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A.

B.

p = 0.52

Figure 23. Ki67 staining in non-proliferative cells. A, Top panel, DAPI staining.
Bottom panel, Ki67 staining of control and MB2 treated cells. B, a bar graph
representing average (mean) Ki67 positive nuclei divided by the number of DAPI (yaxis) in control and increasing concentration of MB2 treated cells (x-axis). The error
bars represent standard deviation of mean (N=2), with 2 wells and a minimum of 200
cells per well per experiment. p-value is calculated by comparing control and MB2
treated cells at 5 µg/ml concentration.
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A.

B.

p = 0.03

Figure 24. Effect of MB2 on the localization of β catenin in non-proliferating S1
cells. A, Top panel, DAPI staining. Bottom panel, β catenin staining of control and MB2
treated cells respectively. B, the difference in the average (mean) number of nuclear βcatenin positive cells divided by number of DAPI (y-axis) in control and increasing
concentration of MB2 treated cells (x-axis). Positive cells are those that have β catenin
staining in the nucleus. The error bars represent standard deviation of mean (N=2), with
2 wells and minimum of 200 cells per well per experiment. p-value is calculated by
comparing control and MB2 treated cells at 5 µg/ml concentration.
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A.

B.
p = 0.04

C.

D.
p = 0.9

34%

38%

Figure 25. γ- H2AX expression in non-proliferating S1 cells and MB2 treated cells.
A and C, DAPI staining. Bottom panel,

γ- H2AX staining of S1 cells (control) and MB2

treated cells after 48 hours. A, S1 cells that are treated with growth medium without
EGF for 4 days and C, 6 days. B and D, comparison of the average (mean) number of

γ-

H2AX positive nuclei divided by number of DAPI (y-axis) in control and with

increasing concentration or 5 µg/ml concentration of MB2 treated cells (x-axis). The
error bars represent standard deviation of mean (N=2), with 2 wells and a minimum of
200 cells per well per experiment. p-value is calculated by comparing control and MB2
treated cells at 5 µg/ml concentration.
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DETERMINING THE EFFECT OF E-CADHERIN ON DNA REPAIR PROTEINS BY
WESTERN BLOT
To follow up on the localization results obtained by indirect immunofluorescence
technique I did western blot to quantify RAD51,

γ-H2AX and β-catenin in control and

MB2 treated cells. In addition to this I also tried to find out whether there are any
changes in the levels of NBS1, MRE11 and RAD50 in control and MB2 treated cells
since, previously the MRE11 foci formation in response to ionizing radiation has also
shown to be altered by ECM. As a first step, I prepared whole cells lysates from control
and MB2 treated cells. For this I grew S1 cells up to ~40% confluence and treated them
with MB2 blocking antibody (5 µg/ml). After 48 hours the cells were trypsinized and
lysed. The whole cell lysates of normal S1 control cells and MB2 treated cells were run
on an SDS PAGE and were examined for the presence of β-catenin (Figure 26), RAD51
and γ-H2AX (Figure 27) and MRE11/RAD50/NBS1 (Figure 28).

Results show no significant difference in the total β-catenin levels between the control
and Mb2 treated cells. But both in proliferative and non-proliferative cells, nuclear βcatenin levels were found to be significantly higher than that of cytoplasmic extract in
MB2 treated cells when compared to normal S1 cells (Figure 26). These results confirm
the

altered

β-catenin

localization

immunofluorescence method.

in

MB2

treated

cells

shown

by

indirect
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Total RAD51 levels were found to be significantly lower (Figure 27 A and B) in
proliferative MB2 treated cells when compared to control cells (P = 0.04). Even though
indirect immunofluorescence results showed an increased RAD51 “foci” in MB2 treated
cells than control, the total RAD51 levels in MB2 treated cells were lower than in control.
This suggested that the localization of the RAD51 is regulated independent of the
protein levels overall. Whether the nuclear blobs of RAD51 represent active complex
ready to repair or inactive complexes that need to be activated are two possibilities to
be explored further.
Furthermore, total

γ-H2AX

was found to be significantly higher in MB2 treated

proliferative cells than untreated cells and results also showed that γ-H2AX levels were
also found to be fluctuating in non-proliferative cells (Figure 27 C). The bands were
quantified and normalized with α-tubulin loading control. The up-regulation of γ-H2AX in
proliferating cells was more consistent than in non-proliferating cells. This may be
possibly aided by the positive effect of MB2 on proliferation that increases γ-H2AX in S
and G2/M phases of the cell cycle.
There is no significant difference in the amount of MRE11, RAD50 and NBS1 proteins in
control and MB2 treated cells either under proliferating or non-proliferating conditions
(Figure 28).
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A.

B.

Nuclear/ cytosolic extract

N=3

Control MB2 Treated

D.

Nuclear/ cytosolic extract

C.

p=0.04

N=2

12

p=0.03

10
8
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2
0

Control
control

MB2 Treated

Figure 26. β-catenin levels in MB2 treated and untreated cells. β-catenin levels in
whole cell, cytosol and nucleus of proliferative cells (A
, B) and non-proliferative cells (C,D). α- tubulin is used as control for whole cell lysate
and cytosol extract, lamin B is used as control for nuclear extracts. B, the nuclear-tocytosolic ratio in control and MB2 treated cells. The error bars represent standard
deviation of mean (N=3). D, a nuclear-cytosolic ratio of β-catenin in MB2 treated cells
when compared to control cells. The error bars represent standard deviation of mean

61

(N=2). p-value is calculated for the bar graphs by comparing control and MB2 treated
cells at 5 µg/ml concentration.

Figure 27. RAD51 and γ- H2AX levels in control and MB2 treated cells. A, western
blot probed for total RAD51 levels in control and MB2 treated cells. α-tubulin was used
as a loading control. B, total RAD51 levels normalized by α-tubulin in control and MB2
treated cells represented as a bar graph. RAD51/ α-tubulin was used a y-axis. The error
bars represent standard deviation of mean (N=3). p-value is calculated by comparing
control and MB2 treated cells at 5 µg/ml concentration. C, a sample blot containing
normal and MB2 treated whole cell lysate from proliferative and non-proliferative cells
probed for γ- H2AX levels. D, α-tubulin normalized γ- H2AX levels in control and MB2
treated cells. The error bars represent standard deviation of mean (N=2). p-value is
calculated by comparing control and MB2 treated cells at 5 µg/ml concentration.
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Figure 28. MRN complex of proteins in control and MB2 treated proliferative cells.
A, a representative western blot of control and MB2 treated lysates collected from
proliferative and non-proliferative S1 cells. The lysates were probed for RAD50, NBS1
and MRE11 and α-tubulin was used as loading control. B, C and D, levels of NBS1,
RAD50 and MRE11 respectively in control and MB2 treated proliferative (+EGF) and
non-proliferative (-EGF) cells. The error bars represent standard deviation of mean
(N=4 for proliferative cells and N=3 for non-proliferative cells). p-value is calculated by
comparing control and MB2 treated cells at 5 µg/ml concentration.
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EFFECTS OF E-CADHERIN ON β1-INTEGRIN EXPRESSION AND ACTIVATION
Previously, β1‐integrin blocking in single cells was shown to abolish the ECM effect on
HR, as well as on foci formation in response to ionizing radiation. Combined with data in
the lietrature that E-cadherin pathway can alter integrin expression and activation I
wanted to determine the effect of E-cadherin blocking on cell surface β1‐integrin
expression and activation by immunostaining non-permeabilized cells, as well as the
total protein levels by western blot.
β1‐integrin cell surface expression in control and MB2 treated cells was not significantly
different either in proliferating or non-proliferating conditions (Figure 29 A, B, C and D).
The total levels of β1‐integrin in control and MB2 treated proliferative and nonproliferative cells measured by western blot also showed no significant difference
(Figure 29 E and F), showing that E-cadherin has no effect on β1‐integrin expression,
localization, or activation.
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A.

B.

C.

D.

E.

F.

Figure 29. Effect of E-cadherin blocking on the total and activated β1-integrin
expression levels. Both in proliferative (A and B), and non-proliferative (D and E),
normal S1 cells and MB2 treated cells were immunostained for cell surface expression
levels of total and activated β1-integrin. The error bars represent standard deviation of
mean (N=2 for both proliferative cells and non-proliferative cells with 3 samples for each
condition per experiment). p-value is calculated by comparing control and MB2 treated
cells at 5 µg/ml concentration. C and F, α-tubulin normalised total levels of β1‐integrin in
control and MB2 treated proliferative and non-proliferative cells respectively. The error
bars represent standard deviation of mean (N=2 for both proliferative cells and nonproliferative cells). p-value is calculated by comparing control and MB2 treated cells at 5
µg/ml concentration.
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INTERACTION OF E-CADHERIN WITH ECM AND HR
Previously, ECM was shown to up-regulate HR in junctioned cells but down regulate it
in single cells via β1-integrin. My protein localization and expression data showed that
E-cadherin prevents repair proteins RAD51 and γ-H2AX from entering into the nucleus,
but does not alter β1-integrin levels. These data prompted the question of whether Ecadherin was involved in mediating HR or the effect of ECM on HR. Therefore, DR-GFP
assay was conducted in S1 DR9 cells. S1 DR9 cells are those that have two direct
repeats of non-functional GFP genes. When one of the GFP genes is cut with I-SceI
endonuclease (encoded by pBAS), it causes a double strand break. If this break is
repaired by HR, then the GFP gene becomes functional and the cells can be identified
and measured by flow cytometry due to the expression of reporter gene in them. GFP
gene remains non-functional if they are repaired by non-homologous end joining. Using
this assay the HR frequency was measured.
To identify whether there is any interaction between E-cadherin, ECM and HR, the DRGFP assay was performed under 4 different conditions. The S1 DR9 cells were grown
up to ~40% confluence and the cells are transfected with pBAS to introduce double
strand break in the presence and / or absence of ECM and E-cadherin (namely - MB2 &
- ECM, + MB2 & - ECM, - MB2 & + ECM and + MB2 & + ECM). 4 - 8 days after the
introduction of DNA break, the HR frequency was measured as GFP positive cells
under 4 different conditions using flow cytometric analysis. pGFP encoding GFP gene
was used as transfection control.
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The HR frequency was found to be higher in MB2 treated when compared to control
cells in the absence of ECM while in the presence of ECM, MB2 abolishes the effect of
ECM on HR (Figure 30). These results suggest that E-cadherin is necessary for the upregulation effect of ECM on HR.
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A.

B.

Figure 30. Frequency of HR in the presence and absence of MB2 and ECM. A, HR
frequency in control and MB2 treated cells without ECM. B, HR frequency in control and
MB2 treated cells in the presence of ECM. The error bars represent standard deviation
of mean (N=2) with a minimum of 3 samples per condition in each experiment. p-value
is calculated by comparing control and MB2 treated cells at 5 µg/ml concentration.
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INTERACTION OF RAD51, ECM AND HR
My results showed that E-cadherin is necessary for mediating the up-regulation effect of
ECM on HR, as well as showing that E-cadherin increases the nuclear accumulation of
RAD51. This begged the question of whether RAD51 is necessary for the ECM effect
on HR. Therefore, as a first step to find out the effect of HR and ECM in the absence of
RAD51, siRNA against RAD51 was used. To identify, the duration during which RAD51
is down regulated by siRNA I transfected RAD51 siRNA and scramble control, 24 hours
after plating 300,000 cells in a 6-well chamber plate.
Lysates were collected from cells transfected with scramble control and RAD51 siRNA
on day 1, 2, 4 and 7 after transfection. Protein concentration in the lysates was
measured using BioRad protein determination kit. RAD51 levels in those lysates were
later measured by performing western blot technique and normalized using their
respective α-tubulin levels and later by scramble controls. RAD51 siRNA was found to
be down regulated during day 1 to ~ day 4 (Figure 31).
Therefore, I planned to introduce double strand break during day1 after RAD51 siRNA
transfection and measure GFP positive cells to find the effects of HR in the absence of
RAD51. For this, I plated S1 DR9 cells on T75 flasks. After 28 hours, the cells were
transfected with RAD51 siRNA and sramble control. Then, the cells were transfected
with pBAS to induce double strand break on the I-SceI recognition site within the nonfinctional GFP gene 18-19 hours after RAD51 siRNA transfection during which RAD51
was down regulated. To find out the effect of ECM and HR in the presence and absence
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of RAD51, double strand break was induced under 4 different conditions namely, in the
absence of ECM and presence of RAD51, in the absence of ECM and RAD51, in the
presence of ECM and RAD51 and in the presence of ECM and absence of RAD51.
GFP positive cells were measured 48 hours after pBAS transfection that induces double
strand break, to measure the frequency of HR under 4 different conditions mentioned
above (to ensure the experiment was completed within the time frame of RAD51 downregulation). Plasmid encoding GFP protein is also transfected for all 4 growth conditions
to measure the transfection efficiency under each condition and also to normalize the
results.
In the absence of ECM, HR was significantly down regulated in RAD51 siRNA
transfected cells ~9-fold than control cells. While in the presence of ECM, the HR
frequency is not significantly down regulated in the presence of RAD51 siRNA (Figure
32). These results could suggest that ECM induces a largely RAD51-independent
pathway of HR, if the siRNA down-regulation of RAD51 was succesful in the presence
of ECM as in its absence. To determine this, lysates were collected from cells that were
treated with scramble siRNA and RAD51 siRNA in the presence and absence of ECM.
When the lysates were probed for RAD51 on a western blot, I was able to see equal
down regulation of RAD51 in the RAD51 siRNA treated cells both in the presence and
absence of ECM (Figure 33).
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A.

B.

Figure 31. Down regulation of RAD51 using siRNA. A, western blot containing
lysates prepared from RAD51 siRNA or scramble sontrol siRNA transfected cells. The
lysates were collected after 1, 2, 4 and 7 days after siRNA transfection. B, RAD51 levels
were quantified from the western blot were shown in the form of bar graph. The RAD51
levels were normalized using their respective scramble control’s RAD51 levels.
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Figure 32. Effect of RAD51 siRNA on HR in the presence and absence of ECM.
The figure shows the HR frequency in RAD51 siRNA and scramble control transfected
cells in the presence and absence of ECM. The error bars represent standard deviation
of mean (N=2), a minimum of 3 samples per condition was used in each experiment. pvalue is calculated by comparing HR frequency of scramble control and RAD51 siRNA
transfected cells in the presence or absence of ECM.
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Figure 33. RAD51 levels in scramble and RAD51 siRNA transfected cells. Western
blot shows the levels of RAD51 in the lysates of scramble siRNA and RAD51 siRNA
transfected S1 cells in the presence and absence of ECM. α-tubulin was used as the
loading control.
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β-CATENIN’S ROLE IN HR AND ITS INTERACTION WITH ECM
Since I was able to see in indirect immunofluorescence and western blot that the β‐
catenin levels are higher in the nucleus of MB2 treated cells I was interested in finding
out whether there was any change in the phosphorylated forms of β catenin. For this I
probed for phosphorylated forms of β-catenin such as β-catenin Tyr-142, Ser-45 and
tyr89. I was not able to see any bands in case of phosphorylated β catenin Ser-45 and
tyr89. But I was able to see a band for phosphorylated β-catenin Tyr-142. There was no
difference in the signal for phosphorylated β-catenin Tyr-142 in control and MB2 treated
proliferative and non-proliferative cells (Figure 34).
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Figure 34. Tyr-142 phosphorylated β-catenin levels in MB2 treated and untreated
cells. The blot shows phosphorylated β catenin Tyr-142 levels in proliferative control
and MB2 treated cells within lane 1 and 2. Lane 3 and 4 has lysates from nonproliferative control and MB2 treated cells. α tubulin was used as the loading control.
The

table

below

shows

the

quantification

phosphorylated β-catenin levels on the blot.

of

α-tubulin

normalized

Tyr-142
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DISCUSSION
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DISCUSSION
Previously our lab showed that in the presence of ECM and cell-cell junctions ECM
signaling up-regulated HR whereas in the absence of cell-cell junction ECM signaling
was found to down regulate HR. Since, in the presence and absence of cell-cell
junctions ECM signaling effects on HR changes, I was interested in identifying cell
junction protein(s) that is responsible for interfering with the ECM signaling on HR.
In mammary epithelial cells, E-cadherin is the main adherens junction protein that is
involved in attaching the adjacent cells together. Reduction in E-cadherin expression
has been found in tumor cells [46]. It has also been reported that inactivating mutations
of E-cadherin gene are highly frequent in infiltrating lobular breast carcinomas and
diffuse gastric carcinomas [47]. E-cadherin is the second most frequently mutated gene
in breast cancer [48].
Therefore, to see whether this cancer relevant protein, E-cadherin is the cell-cell
junction protein that is interacting with HR, I blocked E-cadherin protein function of S1
cells and asked if this altered DNA repair protein localization, expression and HR
function. E-cadherin blocking in the non-tumorigenic S1 cell lines resulted in cell
scattering, loss of contact inhibition, increased proliferation as well as movement of βcatenin into the nucleus.
It is interesting to note that although S1 cells are non-transformed there are other
examples of non-transformed cells responding similarly to E-cadherin blocking. For
example, in ES cells it has been shown that loss of E-cadherin was found to result in
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nuclear localization of β-catenin [49]. These results suggested that S1 cells are
appropriate for studying loss of E-cadherin function and its downstream effector βcatenin.
Blocking E-cadherin in both proliferating and non-proliferating S1 cells increased

γ-

H2AX foci in the nucleus. Large nuclear foci of RAD51 were present in E-cadherin
blocked cells but not in normal S1 cells. These results suggested that E-cadherin blocks
the nuclear localization of

γ-H2AX

and RAD51. This could indicate that proper E-

cadherin containing cell-cell junctions are important in preventing endogenous DNA
damage. When E-cadherin is blocked, cell scattering could upset cellular homeostasis
resulting in increased endogenous DNA damage. Reactive oxygen species are one
potential DNA damage-causing agent that could be induced [50]. Increased DNA
replication and stalled forks could be another way of inducing DNA repair foci in the
absence of exogenous damage. Since our results showed that E-cadherin blocking
increases γ-H2AX foci even in the absence of proliferation it is not necessary to invoke
the S phase replication blocks in explaining the nuclear accumulation of these DNA
repair proteins.
It is interesting to note that in the absence of added ECM, blocking E-cadherin upregulated HR as well as increased the nuclear γ-H2AX and RAD51. These results were
consistent with E-cadherin mediated junction signaling modulating HR via

γ-H2AX and
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RAD51. In fact, in the absence of ECM we found HR to be almost completely RAD51
dependent. In exact opposition to these results, we found both E-cadherin and RAD51
to act very differently for HR in the presence of ECM. RAD51 was not necessary for
most HR in the presence of ECM but E-cadherin was entirely required i.e, E-cadherin
prevents HR in the absence of ECM but it is needed for HR in the presence of ECM.
In trying to decipher the E-cadherin pathway components in the HR regulation, it is
noteworthy to mention that our results revealed an interaction between E-cadherin, an
adherens junction protein, HR proteins and movement of β-catenin into nucleus.
Various studies have shown that β-catenin interacts with LEF/TCF transcription factors
in the nucleus [28]. So, transcriptional regulation of DNA repair related proteins could
contribute to the observed HR effects. Alternatively, β-catenin could signal via multiple
phosphorylation events to cytoplasmic signaling components. Of these Tyr-142, Tyr-86
and Ser-45 have been studied well.
Phosphorylation at Tyr-142 abolishes the interaction between β-catenin and alphacatenin. pp60c-src phosphorylates β-catenin at Tyr-86 and Tyr-654 reducing its affinity
for E-cadherin [39]. Phosphorylation at Ser-45 by an unknown kinase is required for the
GSK-3 to further phosphorylate β-catenin at Thr-41, Ser-37 and Ser-33 that results in
beta-catenin ubiquitination and proteasome-dependent degradation [40].
Finally to find out whether there is any change in the amount of phoshorylated β-catenin
levels in the normal S1 cells and MB2 treated cells, I probed for phosphorylated βcatenin Tyr142, Ser45 and Tyr86 by western blot analysis. I was not able to see any
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difference in the amount of phosphorylated β-catenin Tyr142 levels between control and
MB2 treated cells. Moreover, the levels of phosphorylated β-catenin Tyr86 and Ser45
proteins remained undetectable in control and MB2 treated cells. Thus I was not able to
see any change in the three phosphorylated forms of β-catenin in control and MB2
treated cells.
Apart from these phosphorylated forms of β-catenin, there are also other mutant forms
(especially at the N-terminal end) of β-catenin that are associated with cancer and have
the ability to enter into the nucleus. For example, β-catenin that lacks Ser 45 (3bp
deletion) is a mutant that is not affected by APC leading to an increase in β-cateninLEF4 complex formation in the nucleus. This mutant is seen in colon cancer tumor cell
line HCT116. Another mutant seen in SW48 colon cancer tumor cell line has a single
missense mutation that replaces Ser to Tyr. This mutant is also not affected by APC
leading to an increase in β catenin-LEF4 complex formation in the nucleus. There are
other N-terminal truncated β catenin mutants that do not have GSK-3beta
phosphorylation sites on β catenin. Therefore testing these mutants for their effect on
HR could also give some insights into the role of β catenin in HR. HR experiments
related to β catenin mutants or siRNA against β catenin and E-cadherin will help us to
understand further the role of E-cadherin and β catenin in DNA double strand break
repair directly, as well as in combination with ECM signaling.
For ECM signaling and E-cadherin cross talk we observed here, the primary candidate
protein was β1-integrin. However, we found that blocking E-cadherin did not alter this
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integrin, making it less likely the mediator of ECM to E-cadherin cross talk in modulating
HR. However, experiments blocking β1-integrin need to be performed to determine if it
is functionally relevant for the E-cadherin dependence of the ECM effect on HR.
These results leave us with a model (Figure 35) indicating that ECM can act as a
genome stability enhancer via inducing HR. For this, intact cell-celljunctions are needed
and E-cadherin is necessary for such ECM mediated genome stability. Given that both
proper cell-ECM interactions and proper cell-cell interactions are needed for tissue
integrity, for cells requiring adhesion for cell survival, our results indicate that both
adhesion pathways are needed for proper DNA repair pathway choices and thus
maintenance of a stable genome. Based on our model, we predict that in cancer cells
with either compromised cell-ECM or cell-cell junctions HR will be down regulated
resulting in instability.
In conclusion, E-cadherin was found to interact with DNA repair proteins and this could
occur through ECM signaling pathway since, HR experiments have shown that there is
a cross-talk between E-cadherin and ECM. And this cross talk could be via β-integrin
other than β1 type of integrin. Thus E-cadherin was found to have a new role in DNA
repair apart from its role in cancer. Moreover, HR occurs in a RAD51-independent
manner in the presence of ECM and E-cadherin would interact with this pathway as in
the absence of E-cadherin, HR is down regulated in the presence of ECM. Apart from
this I believe that other than E-cadherin, β-catenin should also be involved in this HR
pathway directly or indirectly since I was able to see changes in the nuclear β-catenin
levels in MB2 blocked cells. Further investigation on the various nuclear forms of β-
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catenin (mutants/phosphorylated forms) in HR will help us to understand its involvement
in the E-cadherin role on HR. Finally, understanding the inter-relationship between Ecadherin, genomic stability and β-catenin will contribute in further understanding normal
breast cell processes, how they get transformed and contribute later on cancer
progression.
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Figure 35. Model for adherens signaling effects on HR and genome stability. 1, In
the presence of both ECM and cell-cell junctions, ECM up-regulates HR. This requires
E-cadherin and HR occurs in a RAD51-independent manner - stable genome
expected. 2, In the absence of cell-cell junction (example: single cells), ECM blocks HR
as well as downregulating RAD51 and γ-H2AX foci– unstable genome expected. 3, In
the absence of ECM, E-cadherin blocks HR and nuclear RAD51 and
unstable genome.

γ-H2AX

–
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